Plasma Fractionation Market, By Product Type (Albumin, Immunoglobulins, Coagulation Factor Concentrates, and Others), By Application (Neurology, Hematology, Immunology, Critical Care, and Others), By End User (Hospitals and Clinics, Clinical Research Laboratories, and Academic Institutes), and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) - Trends, Analysis, and Forecast till 2030

Introduction:

Plasma is least dense liquid component of whole blood which acquires approximately 55% volume of total blood in humans. In plasma most of the part is water and rest is albumin, globulins, fibrinogen, organic nutrients, electrolytes, and hormones. Plasma fractionation is process of separating various components of the blood plasma.  Plasma contains most immunological part of body, therefor it is used in the prevention or treatment of various diseases caused by immunologic disorders as well as infections. Plasma fractionation as a packaging material for industrial applications. Modern plasma fractionation combines manufacturing steps to isolate, in a sequential and integrated manner, the crude fractions that are further purified into individual therapeutic products. Validated dedicated steps inactivate and/or remove infectious agents potentially present in the starting plasma pool. Plasma Fractionation Market accounted for US$ 25.6 billion 2020 and is estimated to be US$ 52.64 billion by 2030 and is anticipated to register a CAGR of 7.5%.

Rising Incidence of immunologic disorders

Rising incidence of immunologic disorders and growing use of immunoglobulin and alpha-1 antitrypsin are major factors driving growth of the plasma fractionation market. In addition, increasing awareness about diseases such as hemophilia, along with rising incidence of sudden spreading of viral diseases across the globe are some among the major factors to raise the stakes for plasma fractionation by diagnostic centers. This factor leads to large-scale protein purification and ultimately propelling growth of the plasma fractionation market. For instance, in June 2017, World Health Organization reported that around 14.4 million liters of plasma from 44 reporting countries was fractionated for the production of plasma-derived medicinal products (PDMP).

Increasing geriatric population

Furthermore, increasing geriatric population with rising immune disorders among them is another factor expected to boost growth of the plasma fractionation market in the near future. However, high processing costs associated with plasma fractionation and availability of substitute to plasma products such as recombinant proteins are some major factors to restrain growth of the plasma fractionation market over the forecast period. Innovation and development in cost effective plasmapheresis equipment’s by manufacturers and increasing number of hemophilic patients can create lucrative opportunity for players operating in the plasma fractionation market.

For detailed understanding of market dynamics, the plasma fractionation market is analyzed across key regions viz North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Each of these regions is analyzed on the basis of market findings across major countries in these regions for a macro-level understanding of the global market. In 2018, the North America plasma fractionation market is accounted for major revenue share in the plasma fractionation market, followed by other regions. Due to increasing use of immunoglobulins in neurological diseases, and availability of appropriate healthcare infrastructure in the countries of the North America region. Europe plasma fractionation market accounted for second-highest market share, in 2018. This is owing to increasing use of immunoglobulins in neurological diseases and growing adoption of prophylaxis treatments for diagnosed patients, and the rising number of registered hemophilic patients in this region. Asia Pacific plasma fractionation market is expected to grow at the highest rate during the forecast period owing to high expenditure for development of proper healthcare infrastructure by governments in the countries in the region.

 

Plasma Fractionation Market, By Product Type:

• Albumin
  • Others
  • Coagulation Factor Concentrates
  • Immunoglobulins

 Plasma Fractionation Market, By Application:

• Neurology
  • Others
  • Critical Care
  • Immunology
  • Hematology

 Plasma Fractionation Market, By End User:

• Hospitals and Clinics
  • Academic Institutes
  • Clinical Research Laboratories

 Plasma Fractionation Market, By Region:

• North America
  • Middle East & Africa
    • Middle East & Africa Plasma Fractionation Market, By Product type
    • Middle East & Africa Plasma Fractionation Market, By Application
    • Middle East & Africa Plasma Fractionation Market, By End User
    • Middle East & Africa Plasma Fractionation Market, By Country
      • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
  • Latin America
    • Latin America Plasma Fractionation Market, By Product type
    • Latin America Plasma Fractionation Market, By Application
    • Latin America Plasma Fractionation Market, By End User
    • Latin America Plasma Fractionation Market, By Country
      • Brazil
      • Mexico
      • Rest of Latin America
  • Asia Pacific
    • Asia Pacific Plasma Fractionation Market, By Product type
    • Asia Pacific Plasma Fractionation Market, By Application
    • Asia Pacific Plasma Fractionation Market, By End User
    • Asia Pacific Plasma Fractionation Market, By Country
      • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific
  • Europe
    • Europe Plasma Fractionation Market, By Product type
    • Europe Plasma Fractionation Market, By Application
    • Europe Plasma Fractionation Market, By End User
    • Europe Plasma Fractionation Market, By Country
      • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • North America Plasma Fractionation Market, By Product type
  • North America Plasma Fractionation Market, By Application
  • North America Plasma Fractionation Market, By End User
  • North America Plasma Fractionation Market, By Country
    • U.S.
    • Canada

Some of the prominent players operating in the plasma fractionation market include CSL Plasma, Inc., Grifols S.A., BioLife Plasma Services L. P., Octapharma Plasma, Inc., Kedrion S.p.A, Bio Product Laboratory Ltd., LFB S.A., Biotest Pharmaceuticals Corporation, Japan Blood Products Organization, and China Biologic Products Holdings, Inc. Advancements in the product , product launches, approvals for manufacturing facility,  and strategic partnerships are some trends witnessed in the plasma fractionation market. For instance, in December 2017, BioLife Plasma Services L. P. had files for FDA approval of a new plasma manufacturing facility in Covington, Georgia to support growing immunology franchise.  

This report segments the plasma fractionation market on the basis of product type, application, end user, and region. On the basis of type, the target market is classified into albumin, immunoglobulins, coagulation factor concentrates, and others. Immunoglobulins product type is accounted for major revenue share in the global market, in 2018, owing to its ability to reduce adverse effect and drug reaction. On the basis of application, the target market is bifurcated into neurology, hematology, immunology, critical care, and others. Neurology application sub-segment is accounted for major revenue share in the global market, in 2018, owing to rising incidences of neurological disorders and increasing aging population across the globe. On the basis of end user, the target market is bifurcated into hospitals and clinics, clinical research laboratories, and academic institutes. Hospitals and clinics accounted major revenue share in the global market, in 2018. This is due to improving infrastructure, and healthcare facilities provided by hospitals, along with increasing off-label (non-approved) use of plasma fractionated products in hospitals for excessive bleeding due to trauma and surgery. Request Report Sample for more Professional and Technical Insights:

Key features of the study:

Prophecy Market Insights provides detailed analysis on plasma fractionation market in our report- Plasma Fractionation Market by product type, application, end user, and region The report provides market size (US$ Mn) and compounded annual growth rate (%) for the forecast period: 2019 – 2029, considering 2018 as the actual year. The report also contains in-depth analysis about market drivers, restraints, opportunities, new product launches, product approval, ongoing trends, customers demand, and regional outlook. The report delivers competitive analysis about leading players in the plasma fractionation market based on various parameters such as company overview, product portfolio, regional presence, financial performance, distribution strategies, key developments, marketing strategies, and future plans. The analysis from the report would acquaint the marketers and management authorities of companies to make the appropriate decision with respect to their future product launch, ongoing trends, market expansion, and marketing tactics used overall the globe. Various strategy matrices include in the report are PEST analysis, PORTER’s five forces analysis, and opportunity map analysis to analyze the plasma fractionation market.

• CSL Plasma, Inc.
  • Company Overview

• • • • Product Portfolio
      • Key Highlights
      • Financial Performance
    • Grifols S.A.
      • Company Overview

• • • • Product Portfolio
      • Key Highlights
      • Financial Performance
    • BioLife Plasma Services L. P.
      • Company Overview

• • • • Product Portfolio
      • Key Highlights
      • Financial Performance
    • Octapharma Plasma, Inc.
      • Company Overview

• • • • Product Portfolio
      • Key Highlights
      • Financial Performance
    • Kedrion S.p.A
      • Company Overview

• • • • Product Portfolio
      • Key Highlights
      • Financial Performance
    • Bio Product Laboratory Ltd.
      • Company Overview

• • • • Product Portfolio
      • Key Highlights
      • Financial Performance
    • LFB S.A.
      • Company Overview

• • • • Product Portfolio
      • Key Highlights
      • Financial Performance
    • Biotest Pharmaceuticals Corporation
      • Company Overview

• • • • Product Portfolio
      • Key Highlights
      • Financial Performance
    • Japan Blood Products Organization
      • Company Overview

• • • • Product Portfolio
      • Key Highlights
      • Financial Performance
    • China Biologic Products Holdings, Inc.
      • Company Overview

• • • • Product Portfolio
      • Key Highlights
      • Financial Performance

1. Research Objective and Assumption
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Preview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Product Type
     • Market Snippet, By Application
     • Market Snippet, By End User
     • Market Snippet, By Region
   • Opportunity Map Analysis
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
   • Market Trends
   • Impact Analysis
   • PEST Analysis
   • Porter’s Analysis
4. Market Segmentation, By Product Type, 2019 – 2029, (US$ Bn)
   • Overview
     • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2019 — 2029
     • Y-o-Y Growth Analysis (%), 2019 – 2029
     • Segment Trends
   • Albumin
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
   • Immunoglobulins
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
   • Coagulation Factor Concentrates
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
   • Others
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
5. Market Segmentation, By Application, 2019 – 2029, (US$ Bn)
   • Overview
     • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2019 — 2029
     • Y-o-Y Growth Analysis (%), 2019 – 2029
     • Segment Trends
   • Neurology
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
   • Hematology
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
   • Immunology
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
   • Critical Care
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
   • Others
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
6. Market Segmentation, By End User, 2019 – 2029, (US$ Bn)
   • Overview
     • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2019 — 2029
     • Y-o-Y Growth Analysis (%), 2019 – 2029
     • Segment Trends
   • Hospitals and Clinics
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
   • Clinical Research Laboratories
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
   • Academic Institutes
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
7. Global Market, By Region, 2019 – 2029, (US$ Bn)
   • Overview
     • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2019 — 2029
     • Y-o-Y Growth Analysis (%), 2019 – 2029
     • Regional Trends
   • North America
     • Market Size and Forecast (US$ Bn), By Product Type, 2019 – 2029
     • Market Size and Forecast (US$ Bn), By Application, 2019 – 2029
     • Market Size and Forecast (US$ Bn), By End User, 2019 – 2029
     • Market Size and Forecast (US$ Bn), By Country, 2019 – 2029
       • U.S.
       • Canada
   • Europe
     • Market Size and Forecast (US$ Bn), By Product Type, 2019 – 2029
     • Market Size and Forecast (US$ Bn), By Application, 2019 – 2029
     • Market Size and Forecast (US$ Bn), By End User, 2019 – 2029
     • Market Size and Forecast (US$ Bn), By Country, 2019 – 2029
       • Germany
       • UK
       • France
       • Russia
       • Italy
       • Rest of Europe
   • Asia Pacific
     • Market Size and Forecast (US$ Bn), By Product Type, 2019 – 2029
     • Market Size and Forecast (US$ Bn), By Application, 2019 – 2029
     • Market Size and Forecast (US$ Bn), By End User, 2019 – 2029
     • Market Size and Forecast (US$ Bn), By Country, 2019 – 2029
       • China
       • India
       • Japan
       • South Korea
       • Rest of Asia Pacific
   • Latin America
     • Market Size and Forecast (US$ Bn), By Product Type, 2019 – 2029
     • Market Size and Forecast (US$ Bn), By Application, 2019 – 2029
     • Market Size and Forecast (US$ Bn), By End User, 2019 – 2029
     • Market Size and Forecast (US$ Bn), By Country, 2019 – 2029
       • Brazil
       • Mexico
       • Rest of Latin America
   • Middle East & Africa
     • Market Size and Forecast (US$ Bn), By Product Type, 2019 – 2029
     • Market Size and Forecast (US$ Bn), By Application, 2019 – 2029
     • Market Size and Forecast (US$ Bn), By End User, 2019 – 2029
     • Market Size and Forecast (US$ Bn), By Country, 2019 – 2029
       • GCC
       • Israel
       • South Africa
       • Rest of Middle East & Africa
8. Competitive Landscape
   • Heat Map Analysis
   • Company Profiles
     • CSL Plasma, Inc.
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
     • Grifols S.A.
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
     • BioLife Plasma Services L. P.
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
     • Octapharma Plasma, Inc.
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
     • Kedrion S.p.A
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
     • Bio Product Laboratory Ltd.
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
     • LFB S.A.
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
     • Biotest Pharmaceuticals Corporation
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
     • Japan Blood Products Organization
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
     • China Biologic Products Holdings, Inc.
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
   • Analyst Views
9. Section
   • Research Methodology
   • About Us
   • Contact